News

Proxima Clinical Research Earns 2022 Great Place to Work(R) Certification Amid Continued Growth and Promotions

96% of employees at Proxima CRO say it is a great place to work compared to 57% of employees at…

2 years ago

Scientific Industries Reports Financial Results for Third Quarter of Fiscal Year 2022

Bioprocessing Continues to Report Strong Revenue GrowthContinued Focus On Driving Digitally Simplified Bioprocessing GrowthInvestor Call to be held May 18th…

2 years ago

Report from the Annual General Meeting of Promore Pharma AB held on 17 May 2022

STOCKHOLM, SWEDEN / ACCESSWIRE / May 17, 2022 / Promore Pharma (STO:PROMO) (FRA:8T0)Promore Pharma AB, reg. no. 556639-6809, held its…

2 years ago

Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd!

Click Here To RSVP for This In-Person, Outdoor EventHuman and Doggy Swag Will Be Available*, and the Event Will Feature…

2 years ago

Leafbuyer Technologies, Inc. Announces Q3 Results: 46% increase in Quarterly Revenue

Financial Highlights:Quarterly Revenue rose to $984,000 from $672,000 in the third quarter of fiscal year 2021Gross Profit increased to $292,682…

2 years ago

Gemina Labs Announces CE Mark for its First Product – The Best in Class Legio-X COVID Rapid Antigen Test

Less than two weeks after announcing the highly successful completion of human trials, Gemina has secured a European Union ("EU")…

2 years ago

Viveve CEO Scott Durbin Named Among Top 50 Healthcare Technology Leaders of 2022 by Healthcare Technology Report

Durbin recognized for second consecutive year for leading development of Viveve's innovative technology for treatment of stress urinary incontinence in…

2 years ago

Report from the Annual General Meeting of AlzeCure Pharma on 17 May 2022

STOCKHOLM, SE / ACCESSWIRE / May 17, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)Today, 17 May 2022, the annual general meeting…

2 years ago

StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Update

TORONTO, ON / ACCESSWIRE / May 17, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS)(OTCQB:SZLSF), a vertically-integrated healthcare…

2 years ago

Moderna Announces Advancements in mRNA Platform Science for Application Across Multiple Diseases at Science and Technology Day

Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a…

2 years ago